ADVEON

Dead / Abandoned — Abandoned — after publication (as of 04 Nov 2015)

What this means for you

This application is over — abandoned 04 Nov 2015. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
86600429
Mark type
Stylized text
Filed
16 Apr 2015
Published for opposition
15 Sept 2015
Abandoned
04 Nov 2015
Attorney of record
Matthew O. Brady

Goods and services

  • Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungals; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; pharmaceutical preparations for use as a neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Owner

Prosecution history

  • 19 Feb 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 21 Jun 2017 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 04 Nov 2015 — ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
  • 04 Nov 2015 — ABANDONMENT - AFTER PUBLICATION
  • 02 Nov 2015 — TEAS EXPRESS ABANDONMENT RECEIVED
  • 12 Oct 2015 — EXTENSION OF TIME TO OPPOSE RECEIVED
  • 15 Sept 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 15 Sept 2015 — PUBLISHED FOR OPPOSITION
  • 26 Aug 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Aug 2015 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 07 Aug 2015 — ASSIGNED TO LIE
  • 27 Jul 2015 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 27 Jul 2015 — EXAMINER'S AMENDMENT ENTERED
  • 27 Jul 2015 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 27 Jul 2015 — EXAMINERS AMENDMENT E-MAILED

View this trademark record on Marksy